Moviprep

Polyethylene glycol 3350 with electrolytes and ascorbic acid, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution for oral use. It is used to cleanse the bowel before colonoscopy, sigmoidoscopy, and radiological examinations of the colon.

GNH USA supplies Moviprep as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moviprep, an osmotic laxative used for bowel preparation, is indicated for:

- Bowel cleansing prior to colonoscopy: achieves thorough colon cleansing to allow clear visualization during the procedure. - Bowel cleansing prior to sigmoidoscopy: provides effective evacuation of stool for optimal sigmoidoscopic examination. - Bowel cleansing prior to radiological examinations of the colon: ensures adequate preparation for contrast imaging of the colon.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal discomfort: cramping or pain in the abdomen. - Bloating: sensation of fullness or gas. - Vomiting: occasional expulsion of stomach contents. - Headache: transient mild headache. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal sodium or potassium levels that may affect heart rhythm. - Acute renal impairment: sudden decline in kidney function. - Severe abdominal pain: intense pain that does not resolve. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hypotension: unusually low blood pressure.

Before using Moviprep, consider the following precautions:

- Assess renal function: evaluate kidney function prior to initiation. - Review electrolyte status: check serum sodium, potassium and other electrolytes. - Ensure adequate hydration: advise patients to drink sufficient fluids during preparation. - Avoid in intestinal obstruction: contraindicated in known or suspected obstruction. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Moviprep may interact with other medicines as follows:

Major Interactions (Avoid): - Other osmotic laxatives: risk of excessive fluid and electrolyte loss. - Antidiarrheal agents (e.g., loperamide): may reduce efficacy of bowel cleansing. - Diuretics or ACE inhibitors: can exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Lithium therapy: fluid shifts may alter lithium serum levels. - Oral rehydration solutions: may affect overall electrolyte composition. - Antacids containing magnesium or aluminum: could interfere with absorption of electrolytes.